Benjamin A Smith

Title: Benjamin A. Smith: Innovator in Antibody Technology

Introduction

Benjamin A. Smith is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-transferrin receptor antibodies. His work has implications for various therapeutic applications, showcasing the potential of innovative antibody technologies.

Latest Patents

Benjamin A. Smith holds a patent for "Anti-transferrin receptor antibodies and uses thereof." This patent provides a comprehensive disclosure of anti-transferrin receptor antibodies, compositions that include these antibodies, and methods for their use. The patent also details polynucleotides and vectors that encode the antibodies, as well as the cells that comprise them. Furthermore, it outlines methods for producing these antibodies and the various molecules that incorporate them.

Career Highlights

Smith is currently associated with Biogen MA Inc., a leading biotechnology company known for its focus on developing therapies for neurological diseases. His role at Biogen has allowed him to work on cutting-edge research and contribute to advancements in antibody technology.

Collaborations

Some of his notable coworkers include Isin Dalkilic-Liddle and Karl J. M. Hanf. Their collaborative efforts in research and development have further enhanced the innovative work being done in the field of antibody therapies.

Conclusion

Benjamin A. Smith's contributions to the field of biotechnology, particularly through his patent on anti-transferrin receptor antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications, demonstrating the importance of innovation in science.